search
Back to results

Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it.

Primary Purpose

Thyroid Goiter, Thyroid Nodule

Status
Completed
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
Bupivacain
Ketorolac
Sponsored by
Sohag University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Thyroid Goiter focused on measuring ketorolac, superficial cervical plexus block, thyroidectomy

Eligibility Criteria

20 Years - 50 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients aged 20-50 years
  • ASA I-II patients
  • Patients going to do thyroid surgeries under general anesthesia

Exclusion Criteria:

  • Patient refusal
  • Known history of sensitivity to the drug used in the study
  • Drug abuse
  • Infection at the site of the block
  • Presence of coagulopathy

Sites / Locations

  • Sohag University Faculty of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

bupivacaine

bupivacaine and ketorolac

Arm Description

Outcomes

Primary Outcome Measures

1st analgesic requirement
The first time of supplemental analgesic need postoperatively

Secondary Outcome Measures

analgesic consumption
total analgesic consumption
postoperative pain
visual analogue scale(0-10) 0=no pain and 10=severe intolerable pain

Full Information

First Posted
December 17, 2021
Last Updated
January 6, 2022
Sponsor
Sohag University
search

1. Study Identification

Unique Protocol Identification Number
NCT05180214
Brief Title
Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it.
Official Title
The Effect of Adding Ketorolac to Bupivacaine in Superficial Cervical Plexus Block in Thyroid Surgery.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
January 17, 2021 (Actual)
Primary Completion Date
August 19, 2021 (Actual)
Study Completion Date
September 15, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sohag University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Thyroidectomy is considered a common operation with moderate to severe postoperative pain in some patients. Patients are divided into two groups. Bupivacaine group received bilateral superficial cervical plexus block (BSCPB) with 10 ml of bupivacaine (0.25%) and 1 ml of normal saline on each side and the Bupivacaine Ketorolac group received (BSCPB) with 10 ml of bupivacaine (0.25%) and 1 ml of ketorolac (15 mg) on each side.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Thyroid Goiter, Thyroid Nodule
Keywords
ketorolac, superficial cervical plexus block, thyroidectomy

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
46 (Actual)

8. Arms, Groups, and Interventions

Arm Title
bupivacaine
Arm Type
Active Comparator
Arm Title
bupivacaine and ketorolac
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Bupivacain
Intervention Description
analgesic
Intervention Type
Drug
Intervention Name(s)
Ketorolac
Intervention Description
analgesia
Primary Outcome Measure Information:
Title
1st analgesic requirement
Description
The first time of supplemental analgesic need postoperatively
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
analgesic consumption
Description
total analgesic consumption
Time Frame
24 hours
Title
postoperative pain
Description
visual analogue scale(0-10) 0=no pain and 10=severe intolerable pain
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients aged 20-50 years ASA I-II patients Patients going to do thyroid surgeries under general anesthesia Exclusion Criteria: Patient refusal Known history of sensitivity to the drug used in the study Drug abuse Infection at the site of the block Presence of coagulopathy
Facility Information:
Facility Name
Sohag University Faculty of Medicine
City
Sohag
ZIP/Postal Code
52514
Country
Egypt

12. IPD Sharing Statement

Learn more about this trial

Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it.

We'll reach out to this number within 24 hrs